Lupin Wins Feds' OK Of Settlement In $850M Gavis Buy
The U.S. Federal Trade Commission said Tuesday it had unanimously approved a settlement under which Lupin Ltd. will divest two generic drugs sold by Gavis Pharmaceuticals LLC, after the FTC claimed...To view the full article, register now.
Already a subscriber? Click here to view full article